Literature DB >> 36038662

The role of α-klotho in human cancer: molecular and clinical aspects.

Hagai Ligumsky1,2, Keren Merenbakh-Lamin1, Noa Keren-Khadmy1, Ido Wolf1,2, Tami Rubinek3,4.   

Abstract

Klotho is a well-established longevity hormone. Its most prominent function is the regulation of phosphate homeostasis. However, klotho possesses multiple pleiotropic activities, including inhibition of major signaling pathways, reducing oxidative stress and suppressing inflammation. These activities are tightly associated with cancer, and klotho was discovered as a universal tumor suppressor. We review here novel molecular aspects of klotho activity in cancer, focusing on its structure-function relationships and clinical aspects regarding its expression, blood levels, clinical risk, and prognostic value in the clinical setting. In addition, the potential benefit of klotho treatment combined with chemotherapy, biological therapy, or immunotherapy, are discussed. Finally, as klotho was shown in preclinical models to inhibit cancer development and growth, we discuss various approaches to developing klotho-based therapies.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36038662     DOI: 10.1038/s41388-022-02440-5

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   8.756


  75 in total

1.  Regulation of fibroblast growth factor-23 signaling by klotho.

Authors:  Hiroshi Kurosu; Yasushi Ogawa; Masayoshi Miyoshi; Masaya Yamamoto; Animesh Nandi; Kevin P Rosenblatt; Michel G Baum; Susan Schiavi; Ming-Chang Hu; Orson W Moe; Makoto Kuro-o
Journal:  J Biol Chem       Date:  2006-01-25       Impact factor: 5.157

2.  Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice.

Authors:  Shigehiro Doi; Yonglong Zou; Osamu Togao; Johanne V Pastor; George B John; Lei Wang; Kazuhiro Shiizaki; Russell Gotschall; Susan Schiavi; Noriaki Yorioka; Masaya Takahashi; David A Boothman; Makoto Kuro-O
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

3.  Mutation of the mouse klotho gene leads to a syndrome resembling ageing.

Authors:  M Kuro-o; Y Matsumura; H Aizawa; H Kawaguchi; T Suga; T Utsugi; Y Ohyama; M Kurabayashi; T Kaname; E Kume; H Iwasaki; A Iida; T Shiraki-Iida; S Nishikawa; R Nagai; Y I Nabeshima
Journal:  Nature       Date:  1997-11-06       Impact factor: 49.962

4.  Suppression of aging in mice by the hormone Klotho.

Authors:  Hiroshi Kurosu; Masaya Yamamoto; Jeremy D Clark; Johanne V Pastor; Animesh Nandi; Prem Gurnani; Owen P McGuinness; Hirotaka Chikuda; Masayuki Yamaguchi; Hiroshi Kawaguchi; Iichiro Shimomura; Yoshiharu Takayama; Joachim Herz; C Ronald Kahn; Kevin P Rosenblatt; Makoto Kuro-o
Journal:  Science       Date:  2005-08-25       Impact factor: 47.728

5.  Klotho suppresses growth and invasion of colon cancer cells through inhibition of IGF1R-mediated PI3K/AKT pathway.

Authors:  Xin-Xiang Li; Li-Yong Huang; Jun-Jie Peng; Lei Liang; De-Bing Shi; Hong-Tu Zheng; San-Jun Cai
Journal:  Int J Oncol       Date:  2014-05-09       Impact factor: 5.650

6.  Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer.

Authors:  I Wolf; S Levanon-Cohen; S Bose; H Ligumsky; B Sredni; H Kanety; M Kuro-o; B Karlan; B Kaufman; H P Koeffler; T Rubinek
Journal:  Oncogene       Date:  2008-09-01       Impact factor: 9.867

7.  alpha-Klotho as a regulator of calcium homeostasis.

Authors:  Akihiro Imura; Yoshihito Tsuji; Miyahiko Murata; Ryota Maeda; Koji Kubota; Akiko Iwano; Chikashi Obuse; Kazuya Togashi; Makoto Tominaga; Naoko Kita; Ken-ichi Tomiyama; Junko Iijima; Yoko Nabeshima; Makio Fujioka; Ryo Asato; Shinzo Tanaka; Ken Kojima; Juichi Ito; Kazuhiko Nozaki; Nobuo Hashimoto; Tetsufumi Ito; Takeshi Nishio; Takashi Uchiyama; Toshihiko Fujimori; Yo-ichi Nabeshima
Journal:  Science       Date:  2007-06-15       Impact factor: 47.728

8.  Inhibition of lung cancer cells growth, motility and induction of apoptosis by Klotho, a novel secreted Wnt antagonist, in a dose-dependent manner.

Authors:  Bo Chen; Xiaoli Ma; Shifeng Liu; Weihong Zhao; Jianqing Wu
Journal:  Cancer Biol Ther       Date:  2012-08-24       Impact factor: 4.742

Review 9.  Targeting insulin-like growth factor pathways.

Authors:  D Yee
Journal:  Br J Cancer       Date:  2006-02-27       Impact factor: 7.640

10.  A Klotho-derived peptide protects against kidney fibrosis by targeting TGF-β signaling.

Authors:  Qian Yuan; Qian Ren; Li Li; Huishi Tan; Meizhi Lu; Yuan Tian; Lu Huang; Boxin Zhao; Haiyan Fu; Fan Fan Hou; Lili Zhou; Youhua Liu
Journal:  Nat Commun       Date:  2022-01-21       Impact factor: 17.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.